Tel Aviv - Delayed Quote ILA

Together Pharma Ltd (TGTR.TA)

413.10
+0.60
+(0.15%)
As of 12:08:02 PM GMT+3. Market Open.
Loading Chart for TGTR.TA
  • Previous Close 412.50
  • Open 413.00
  • Bid 404.00 x --
  • Ask 413.10 x --
  • Day's Range 413.00 - 413.10
  • 52 Week Range 360.00 - 615.00
  • Volume 2,056
  • Avg. Volume 15,627
  • Market Cap (intraday) 57.026M
  • Beta (5Y Monthly) 0.31
  • PE Ratio (TTM) --
  • EPS (TTM) -0.22
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date Mar 29, 2011
  • 1y Target Est --

Together Pharma Ltd, through its subsidiaries, engages in growing, production, storage, and distribution of medical cannabis products in Israel. The company was incorporated in 1991 and is based in Ashkelon, Israel.

www.together-pharma.com

199

Full Time Employees

December 31

Fiscal Year Ends

Recent News: TGTR.TA

View More

Performance Overview: TGTR.TA

Trailing total returns as of 5/19/2025, which may include dividends or other distributions. Benchmark is TA-125 (^TA125.TA) .

YTD Return

TGTR.TA
5.46%
TA-125 (^TA125.TA)
10.73%

1-Year Return

TGTR.TA
25.31%
TA-125 (^TA125.TA)
36.45%

3-Year Return

TGTR.TA
48.17%
TA-125 (^TA125.TA)
38.61%

5-Year Return

TGTR.TA
86.66%
TA-125 (^TA125.TA)
91.09%

Compare To: TGTR.TA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: TGTR.TA

View More

Valuation Measures

Annual
As of 5/18/2025
  • Market Cap

    56.89M

  • Enterprise Value

    56.89M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -1.22%

  • Return on Assets (ttm)

    1.43%

  • Return on Equity (ttm)

    -9.09%

  • Revenue (ttm)

    96.05M

  • Net Income Avi to Common (ttm)

    -1.17M

  • Diluted EPS (ttm)

    -0.22

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    8.44M

  • Total Debt/Equity (mrq)

    166.35%

  • Levered Free Cash Flow (ttm)

    2.55M

Research Analysis: TGTR.TA

View More

Company Insights: TGTR.TA

Research Reports: TGTR.TA

View More

People Also Watch